{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:23:16Z","timestamp":1758403396037,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005378","name":"Hacettepe \u00dcniversitesi","doi-asserted-by":"publisher","award":["THD-2019-18223"],"award-info":[{"award-number":["THD-2019-18223"]}],"id":[{"id":"10.13039\/501100005378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s42000-024-00558-7","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T03:44:05Z","timestamp":1713411845000},"page":"777-788","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-5683","authenticated-orcid":false,"given":"Busra","family":"Firlatan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9146-8765","authenticated-orcid":false,"given":"Ugur Nadir","family":"Karakulak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3542-894X","authenticated-orcid":false,"given":"Vedat","family":"Hekimsoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8133-0313","authenticated-orcid":false,"given":"Burcin Gonul","family":"Iremli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1466-5746","authenticated-orcid":false,"given":"Incilay","family":"Lay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0725-5447","authenticated-orcid":false,"given":"Deniz","family":"Yuce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0513-1750","authenticated-orcid":false,"given":"Selcuk","family":"Dagdelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3275-7003","authenticated-orcid":false,"given":"Giray","family":"Kabakci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1377-9394","authenticated-orcid":false,"given":"Tomris","family":"Erbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"key":"558_CR1","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/eurheartj\/ehab822","volume":"43","author":"S Hong","year":"2022","unstructured":"Hong S, Kim KS, Han K et al (2022) Acromegaly and cardiovascular outcomes: a cohort study. Eur Heart J 43:1491\u20131499. https:\/\/doi.org\/10.1093\/eurheartj\/ehab822","journal-title":"Eur Heart J"},{"key":"558_CR2","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/j.1540-8175.2010.01179.x","volume":"27","author":"E Akgul","year":"2010","unstructured":"Akgul E, Tokgozoglu SL, Erbas T et al (2010) Evaluation of the impact of treatment on endothelial function and cardiac performance in acromegaly. Echocardiography 27:990\u2013996. https:\/\/doi.org\/10.1111\/j.1540-8175.2010.01179.x","journal-title":"Echocardiography"},{"key":"558_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/00015385.2021.1948206","volume":"77","author":"SN Sendur","year":"2022","unstructured":"Sendur SN, Hazirolan T, Aydin B et al (2022) Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly. Acta Cardiol 77:350\u2013359. https:\/\/doi.org\/10.1080\/00015385.2021.1948206","journal-title":"Acta Cardiol"},{"key":"558_CR4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s11102-022-01266-4","volume":"25","author":"S Chiloiro","year":"2022","unstructured":"Chiloiro S, Giampietro A, Gagliardi I et al (2022) Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience. Pituitary 25:831\u2013841. https:\/\/doi.org\/10.1007\/s11102-022-01266-4","journal-title":"Pituitary"},{"key":"558_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1161\/01.Res.0000202805.73038.48","volume":"98","author":"T Kempf","year":"2006","unstructured":"Kempf T, Eden M, Strelau J et al (2006) The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia\/reperfusion injury. Circ Res 98:351\u2013360. https:\/\/doi.org\/10.1161\/01.Res.0000202805.73038.48","journal-title":"Circ Res"},{"key":"558_CR6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41574-021-00529-7","volume":"17","author":"D Wang","year":"2021","unstructured":"Wang D, Day EA, Townsend LK et al (2021) GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat Rev Endocrinol 17:592\u2013607. https:\/\/doi.org\/10.1038\/s41574-021-00529-7","journal-title":"Nat Rev Endocrinol"},{"key":"558_CR7","doi-asserted-by":"publisher","first-page":"e000399","DOI":"10.1161\/jaha.113.000399","volume":"2","author":"V Xanthakis","year":"2013","unstructured":"Xanthakis V, Larson MG, Wollert KC et al (2013) Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening. J Am Heart Assoc 2:e000399. https:\/\/doi.org\/10.1161\/jaha.113.000399","journal-title":"J Am Heart Assoc"},{"key":"558_CR8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/01.RES.0000202804.84885.d0","volume":"98","author":"J Xu","year":"2006","unstructured":"Xu J, Kimball TR, Lorenz JN et al (2006) GDF15\/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 98:342\u2013350. https:\/\/doi.org\/10.1161\/01.RES.0000202804.84885.d0","journal-title":"Circ Res"},{"key":"558_CR9","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/eurjhf\/hfs130","volume":"14","author":"R Santhanakrishnan","year":"2012","unstructured":"Santhanakrishnan R, Chong JP, Ng TP et al (2012) Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction. Eur J Heart Fail 14:1338\u20131347. https:\/\/doi.org\/10.1093\/eurjhf\/hfs130","journal-title":"Eur J Heart Fail"},{"key":"558_CR10","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/echo.14373","volume":"36","author":"S Fang","year":"2019","unstructured":"Fang S, Zhang Z, Wang Y et al (2019) Predictive value of left ventricular myocardial strain by four-dimensional speckle tracking echocardiography combined with red cell distribution width in heart failure with preserved ejection fraction. Echocardiography 36:1074\u20131083. https:\/\/doi.org\/10.1111\/echo.14373","journal-title":"Echocardiography"},{"key":"558_CR11","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1136\/heartjnl-2014-305538","volume":"100","author":"K Kalam","year":"2014","unstructured":"Kalam K, Otahal P, Marwick TH (2014) Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart 100:1673\u20131680. https:\/\/doi.org\/10.1136\/heartjnl-2014-305538","journal-title":"Heart"},{"key":"558_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11102-017-0795-9","volume":"20","author":"ICM Volschan","year":"2017","unstructured":"Volschan ICM, Kasuki L, Silva CMS et al (2017) Two-dimensional speckle tracking echocardiography demonstrates no effect of active acromegaly on left ventricular strain. Pituitary 20:349\u2013357. https:\/\/doi.org\/10.1007\/s11102-017-0795-9","journal-title":"Pituitary"},{"key":"558_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.5603\/EP.a2020.0021","volume":"71","author":"A Popielarz-Grygalewicz","year":"2020","unstructured":"Popielarz-Grygalewicz A, Stelmachowska-Bana\u015b M, G\u0105sior JS et al (2020) Subclinical left ventricular systolic dysfunction in patients with naive acromegaly - assessment with two-dimensional speckle-tracking echocardiography: retrospective study. Endokrynol Pol 71:227\u2013234. https:\/\/doi.org\/10.5603\/EP.a2020.0021","journal-title":"Endokrynol Pol"},{"key":"558_CR14","doi-asserted-by":"publisher","first-page":"812964","DOI":"10.3389\/fendo.2022.812964","volume":"13","author":"P Gadelha","year":"2022","unstructured":"Gadelha P, Santos ECL, Castillo J et al (2022) Subclinical ventricular dysfunction in long-term acromegaly assessed by Speckle-Tracking Echocardiography. Front Endocrinol (Lausanne) 13:812964. https:\/\/doi.org\/10.3389\/fendo.2022.812964","journal-title":"Front Endocrinol (Lausanne)"},{"key":"558_CR15","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1210\/jc.2009-2670","volume":"95","author":"A Giustina","year":"2010","unstructured":"Giustina A, Chanson P, Bronstein MD et al (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141\u20133148. https:\/\/doi.org\/10.1210\/jc.2009-2670","journal-title":"J Clin Endocrinol Metab"},{"key":"558_CR16","doi-asserted-by":"publisher","unstructured":"Hussein Z, Slack RW, Marcus HJ et al (2023) Post-operative medium- and long-term endocrine outcomes in patients with Non-functioning Pituitary Adenomas-Machine Learning Analysis. Cancers (Basel) 15. https:\/\/doi.org\/10.3390\/cancers15102771","DOI":"10.3390\/cancers15102771"},{"key":"558_CR17","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W et al (2018) 2018 ESC\/ESH guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J 39:3021\u20133104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339","journal-title":"Eur Heart J"},{"key":"558_CR18","doi-asserted-by":"publisher","unstructured":"Classification and Diagnosis of Diabetes Standards of Medical Care in Diabetes-2019. Diabetes Care 42:S13\u2013s28. https:\/\/doi.org\/10.2337\/dc19-S002","DOI":"10.2337\/dc19-S002"},{"key":"558_CR19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/circulationaha.107.699579","volume":"117","author":"RB D\u2019agostino","year":"2008","unstructured":"D\u2019agostino RB, Sr., Vasan RS, Pencina MJ et al (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117:743\u2013753. https:\/\/doi.org\/10.1161\/circulationaha.107.699579","journal-title":"Circulation"},{"key":"558_CR20","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440\u20131463. https:\/\/doi.org\/10.1016\/j.echo.2005.10.005","journal-title":"J Am Soc Echocardiogr"},{"key":"558_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233\u2013270. https:\/\/doi.org\/10.1093\/ehjci\/jev014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"558_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21037\/cdt.2017.06.01","volume":"8","author":"D Muraru","year":"2018","unstructured":"Muraru D, Niero A, Rodriguez-Zanella H et al (2018) Three-dimensional speckle-tracking echocardiography: benefits and limitations of integrating myocardial mechanics with three-dimensional imaging. Cardiovasc Diagn Ther 8:101\u2013117. https:\/\/doi.org\/10.21037\/cdt.2017.06.01","journal-title":"Cardiovasc Diagn Ther"},{"key":"558_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjci\/jer316","volume":"13","author":"RM Lang","year":"2012","unstructured":"Lang RM, Badano LP, Tsang W et al (2012) EAE\/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging 13:1\u201346. https:\/\/doi.org\/10.1093\/ehjci\/jer316","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"558_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1365-2265.2011.04019.x","volume":"75","author":"CN Jayasena","year":"2011","unstructured":"Jayasena CN, Comninos AN, Clarke H et al (2011) The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly. Clin Endocrinol (Oxf) 75:220\u2013225. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04019.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"558_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1046\/j.1365-2265.2003.01689.x","volume":"58","author":"A Colao","year":"2003","unstructured":"Colao A, Marzullo P, Cuocolo A et al (2003) Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide. Clin Endocrinol (Oxf) 58:169\u2013176. https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01689.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"558_CR26","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.hlc.2017.08.017","volume":"27","author":"MJ Fung","year":"2018","unstructured":"Fung MJ, Leung DY, Thomas L (2018) Differential Myocardial Fibre involvement by Strain Analysis in patients with aortic stenosis. Heart Lung Circ 27:1357\u20131367. https:\/\/doi.org\/10.1016\/j.hlc.2017.08.017","journal-title":"Heart Lung Circ"},{"key":"558_CR27","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s40618-014-0147-9","volume":"37","author":"R Jurcut","year":"2014","unstructured":"Jurcut R, G\u0103loiu S, Florian A et al (2014) Quantifying subtle changes in cardiovascular mechanics in acromegaly: a Doppler myocardial imaging study. J Endocrinol Invest 37:1081\u20131090. https:\/\/doi.org\/10.1007\/s40618-014-0147-9","journal-title":"J Endocrinol Invest"},{"key":"558_CR28","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/ejhf.1170","volume":"20","author":"PM Seferovi\u0107","year":"2018","unstructured":"Seferovi\u0107 PM, Petrie MC, Filippatos GS et al (2018) Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 20:853\u2013872. https:\/\/doi.org\/10.1002\/ejhf.1170","journal-title":"Eur J Heart Fail"},{"key":"558_CR29","doi-asserted-by":"publisher","first-page":"e13475","DOI":"10.1111\/eci.13475","volume":"51","author":"IA Minciun\u0103","year":"2021","unstructured":"Minciun\u0103 IA, Hilda Or\u0103\u0219an O, Minciun\u0103 I et al (2021) Assessment of subclinical diabetic cardiomyopathy by speckle-tracking imaging. Eur J Clin Invest 51:e13475. https:\/\/doi.org\/10.1111\/eci.13475","journal-title":"Eur J Clin Invest"},{"key":"558_CR30","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s10554-023-02810-4","volume":"39","author":"SM Ghoreyshi-Hefzabad","year":"2023","unstructured":"Ghoreyshi-Hefzabad SM, Jeyaprakash P, Vo HQ et al (2023) Subclinical systolic dysfunction detected by 2D speckle tracking echocardiography in adults with diabetes mellitus: systematic review and meta-analysis of 6668 individuals with diabetes mellitus and 7218 controls. Int J Cardiovasc Imaging 39:977\u2013989. https:\/\/doi.org\/10.1007\/s10554-023-02810-4","journal-title":"Int J Cardiovasc Imaging"},{"key":"558_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/clc.24136","author":"J Gao","year":"2023","unstructured":"Gao J, Xu M, Gong M et al (2023) Left ventricular longitudinal strain in patients with type 2 diabetes mellitus is independently associated with glycated hemoglobin level. Clin Cardiolhttps:\/\/doi. https:\/\/doi.org\/10.1002\/clc.24136","journal-title":"Clin Cardiolhttps:\/\/doi"},{"key":"558_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","volume":"14","author":"A Jabbar","year":"2017","unstructured":"Jabbar A, Pingitore A, Pearce SH et al (2017) Thyroid hormones and cardiovascular disease. Nat Rev Cardiol 14:39\u201355. https:\/\/doi.org\/10.1038\/nrcardio.2016.174","journal-title":"Nat Rev Cardiol"},{"key":"558_CR33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/echo.14307","volume":"36","author":"LY Kong","year":"2019","unstructured":"Kong LY, Gao X, Ding XY et al (2019) Left ventricular end-diastolic strain rate recovered in hypothyroidism following levothyroxine replacement therapy: a strain rate imaging study. Echocardiography 36:707\u2013713. https:\/\/doi.org\/10.1111\/echo.14307","journal-title":"Echocardiography"},{"key":"558_CR34","doi-asserted-by":"publisher","first-page":"e012433","DOI":"10.1161\/circimaging.121.012433","volume":"14","author":"WH Huang","year":"2021","unstructured":"Huang WH, Sung KT, Kuo JY et al (2021) Atrioventricular longitudinal mechanics using Novel Speckle-Tracking Improved Risk Stratification Beyond baseline thyroid hormone in asymptomatic subclinical hypothyroidism. Circ Cardiovasc Imaging 14:e012433. https:\/\/doi.org\/10.1161\/circimaging.121.012433","journal-title":"Circ Cardiovasc Imaging"},{"key":"558_CR35","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1161\/circulationaha.114.011204","volume":"130","author":"L Wallentin","year":"2014","unstructured":"Wallentin L, Hijazi Z, Andersson U et al (2014) Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for reduction in stroke and other thromboembolic events in Atrial Fibrillation (ARISTOTLE) trial. Circulation 130:1847\u20131858. https:\/\/doi.org\/10.1161\/circulationaha.114.011204","journal-title":"Circulation"},{"key":"558_CR36","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3346\/jkms.2016.31.9.1413","volume":"31","author":"MY Shin","year":"2016","unstructured":"Shin MY, Kim JM, Kang YE et al (2016) Association between growth differentiation factor 15 (GDF15) and Cardiovascular Risk in patients with newly diagnosed type 2 diabetes Mellitus. J Korean Med Sci 31:1413\u20131418. https:\/\/doi.org\/10.3346\/jkms.2016.31.9.1413","journal-title":"J Korean Med Sci"},{"key":"558_CR37","doi-asserted-by":"publisher","first-page":"472","DOI":"10.4093\/dmj.2014.38.6.472","volume":"38","author":"JH Hong","year":"2014","unstructured":"Hong JH, Chung HK, Park HY et al (2014) GDF15 is a novel biomarker for impaired fasting glucose. Diabetes Metab J 38:472\u2013479. https:\/\/doi.org\/10.4093\/dmj.2014.38.6.472","journal-title":"Diabetes Metab J"},{"key":"558_CR38","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/clc.23159","volume":"42","author":"S Xie","year":"2019","unstructured":"Xie S, Lu L, Liu L (2019) Growth differentiation factor-15 and the risk of cardiovascular diseases and all-cause mortality: a meta-analysis of prospective studies. Clin Cardiol 42:513\u2013523. https:\/\/doi.org\/10.1002\/clc.23159","journal-title":"Clin Cardiol"},{"key":"558_CR39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/dom.13519","volume":"21","author":"A Natali","year":"2019","unstructured":"Natali A, Nesti L, Venturi E et al (2019) Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: a nested, case-control study. Diabetes Obes Metab 21:412\u2013416. https:\/\/doi.org\/10.1111\/dom.13519","journal-title":"Diabetes Obes Metab"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00558-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-024-00558-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00558-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T10:11:25Z","timestamp":1730110285000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-024-00558-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["558"],"URL":"https:\/\/doi.org\/10.1007\/s42000-024-00558-7","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"type":"print","value":"1109-3099"},{"type":"electronic","value":"2520-8721"}],"subject":[],"published":{"date-parts":[[2024,4,18]]},"assertion":[{"value":"24 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Non-interventional Clinical Research Ethics Board of the Hacettepe University (Project Number # GO 19\/302).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}